Kaleido Biosciences (KLDO) Financials

$0.00

$0.00 (0.00%)

As on 10-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	1.10	0.98	--	--
Cost of Revenue	--	--	2.36	0.06	1.32	--
Gross Profit	--	--	-1.25	0.98	-1.32	--
Operating Expenses	--	--	86.41	79.85	86.66	60.68
Operating Profit (EBIT)	--	--	-87.67	-78.87	-86.66	-60.68
Other Income	--	--	--	0.06	1.31	--
Profit before Tax	--	--	-90.29	-81.62	-86.33	-61.74
Provision for Tax	--	--	2.98	-1.82	-1.32	-0.06
Profit after Tax (Net Income)	--	--	-90.29	-79.80	-85.01	-61.74
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-90.29	-81.62	-86.33	-61.74

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	--	--	10.61	20.50	48.88	58.20
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	9.85	22.19	23.05	15.83
Current Liabilities	--	--	29.68	16.66	10.38	11.30
Total Liabilities	--	--	50.14	59.34	82.31	85.33

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	--	--	7.83	13.12	9.03	9.08
Current Assets	--	--	42.31	48.72	73.28	76.24
Total Assets	--	--	50.14	59.34	82.31	85.33
Total Debt*	--	--	21.69	21.01	20.46	14.92
Net Current Assets	--	--	12.63	32.06	62.90	64.94

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	--	-77.09	-61.52	-75.80	-46.32
Cash Flow from Investing Activities	--	--	-0.69	-4.02	-3.59	-3.00
Cash from Financing Activities	--	--	70.04	40.40	74.64	98.91
Net Cash Inflow / Outflow	--	--	--	-25.14	-4.74	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	-2.12	-2.22	-2.82	-2.10
Cash EPS ($)	--	--	-2.06	-2.17	-2.78	-2.07
Adjusted Book Value ($)	--	--	0.25	0.57	1.62	1.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-1.81	-1.71	-2.51	-1.58
Free Cash Flow per Share ($)	--	--	-1.84	-1.82	-2.63	-1.68

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	--	-244.66	-143.98	-119.35	-278.43
ROE (%)	--	--	-580.57	-230.03	-158.79	-850.70
ROA (%)	--	--	-164.94	-112.67	-101.43	-106.39
EBIT Margin (%)	--	--	-7,940.85	-8,089.64	--	--
Net Margin (%)	--	--	-8,178.26	-7,739.67	-6,509.42	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	0.13	--	--	--
EBIT Growth (%)	--	--	-11.15	8.98	-44.87	-121.44
Net Profit Growth (%)	--	--	-13.15	6.14	-37.69	-124.04
EPS Growth (%)	--	--	0.04	0.21	-0.34	-0.71
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	-1.13	-4.10	-1.78	--
Price / Book Value	0.00	--	9.60	15.98	3.10	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.20	--	-1.00	-3.92	-1.18	--
Close Price ($)	0.00	0.00	2.39	9.10	5.02	--
High Price ($)	0.03	2.73	20.50	11.89	19.00	--
Low Price ($)	--	0.00	2.37	2.82	4.61	--
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	2.05	1.03	0.42	0.26
Short term debt to equity ratio	--	--	1.52	0.13	0.00	0.00
Current Ratio	--	--	1.43	2.92	7.06	6.75
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	-30.89	-28.15	-88.70	-59.52

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	84.60	--	--	--
Asset Turnover	--	--	0.02	0.01	--	--
Receivable days	--	--	309.01	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	856.51	24,163.13	756.27	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.